The role of poverty in antimicrobial resistance

Journal of the American Board of Family Medicine

Volumn 20, Issue 6, 2007, Pages 533-539

  Planta, Margaret B ^a,b  

^a Sutter Medical Group   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEPHALOSPORIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; DEVELOPING COUNTRY; DRUG POTENCY; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH SERVICE; PATIENT COMPLIANCE; PHARYNGITIS; POVERTY; REVIEW; SOCIOECONOMICS; UNITED STATES;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HUMANS; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; POVERTY; PRESCRIPTIONS, DRUG; RISK FACTORS; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 37549017318     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.2007.06.070019     Document Type: Review

References (36)

1. World Health Organization. Overcoming antimicrobial resistance. World Health Organization report on infectious diseases. World Health Organization; 2000.
2. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ. 1998;317:647-50.
3. Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 1999;5:18-27.
4. World Health Organization. World health report. Changing history. World Health Organization; 2004.
5. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet. 1997;349:1269-76.
6. Hossain MA, Rahman M, Ahmed QS, Malek MA, Sack RB, Albert MJ. Increasing frequency of mecillinam-resistant shigella isolates in urban Dhaka and rural Matlab, Bangladesh: a 6-year observation. J Antimicrob Chemother. 1998;42:99-102.
7. Mirza SH, Beeching NJ, Hart CA. Multi-drug resistant typhoid: a global problem. J Med Microbiol. 1996;44:317-9.
8. Klugman KP. Management of antibiotic-resistant pneumococcal infections. J Antimicrob Chemother. 1994;34:191-4.
9. Ross JDC. Fluoroquinolone resistance in gonorrhoea: how, where and so what. Int J STD AIDS. 1998;9:318-22.
10. Munoz R, Coffey TJ, Daniels M, et al. Intercontinental spread of a multi-resistant clone of serotype-23F Streptococcus pneumoniae. J Infect Dis. 1991;164:302-6.
11. Mamun KZ. Prevalence and genetics of resistance to commonly used antimicrobial agents in faecal enterobacteriaceae from children in Bangladesh [PhD thesis]. University of Liverpool; 1991.
12. Hossain MM, Glass RI, Khan MR. Antibiotic use in a rural community in Bangladesh. Int J Epidemiol. 1982;11:402-5.
13. Lansang MA, Lucas-Aquino R, Tupasi TE, et al. Purchase of antibiotics without prescription in Manila, the Philippines. Inappropriate choices and doses. J Clin Epidemiol. 1990;43:61-7.
14. DeNavas-Walt C, Proctor BD, Lee CH. Income, poverty and health insurance coverage in the United States: 2005. Washington, DC: U.S. Census Bureau; 2006:60-231.
15. Wan H, Sengupta M, Velkoff V, DeBarros K. 65+ in the United States: 2005. Washington, DC: US Census Bureau; 2005:23-209.
16. Macias EP, Morales LS. Crossing the border for health care. J Health Care Poor Underserved. 2001;12:77-87.
17. Larson E, Lin SX, Gomez-Duarte C. Antibiotic use in hispanic households, New York City. Emerg Infect Dis. 2003;9:1096-102.
18. McKee MD, Mills L, Mainous AG III. Antibiotic use for the treatment of upper respiratory infections in a diverse community. J Fam Pract. 1999;48:993-6.
19. Richman PB, Garra G, Eskin B, Nashed AH, Cody R. Oral antibiotic use without consulting a physician: a survey of ED patients. Am J Emerg Med. 2001;19:57-60.
20. Statement of William K. Hubbard, Associate Commissioner for Policy and Planning, Joint Hearing of the Subcommittee on Health Care and Subcommittee on International Trade, Committee on Finance, United States Senate. 2004 April 27.
21. Doern GV, Richter SS, Miller A, Miller N, Rice C, Heilmann K, Beekmann S. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis. 2005;41:139-48. Epub 2005 Jun 7.
22. Fox KK, Knapp JS, Holmes KK, et al. Antimicrobial resistance in Neisseria gonorrhoeae in the United States, 1988-1994: the emergence of decreased susceptibility to the fluoroquinolones. J Infect Dis. 1997;175:1396-403.
23. Centers for Disease Control and Prevention. Outbreak of multidrug-resistant Salmonella newport-United States, January-April 2002. MMWR Morb Mortal Wkly Rep. 2002;51:545-8.
24. Vasquez Y, Hand WL. Antibiotic susceptibility patterns of community-acquired urinary tract infection isolates from female patients on the US (Texas)-Mexico border. J Appl Res. 2004;4(2):321-6.
25. Seppala H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med. 1997;337:441-6.
26. Aranson VA, Sigurdsson JA, Erlendsdottir H, Gudmundsson S, Kristinsson KG. The role of antimicrobial use in the epidemiology of resistant pneumococci: a 10-year follow up. Microb Drug Resist. 2006;12:169-76.
27. Van Duong D, Binns CW, Van Le T. Availability of antibiotics as over-the-counter drugs in pharmacies: a threat to public health in Vietnam. Trop Med Int Health. 1997;2:1133-9.
28. Casey JR, Pichichero ME. Meta-analysis of short-course antibiotic treatment for group a streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2005;24:909-17.
29. Schrag SJ, Pena C, Fenandez J, et al. Effect of short-course, high-dose amoxicillin therapy on resistant pneumococcal carriage. JAMA. 2001;286:49-56.
30. Perz JF, Craig AS, Coffey CS, et al. Changes in antibiotic prescribing for children after a community-wide campaign. JAMA. 2002;287:3103-9.
31. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1-7.
32. Gonzales R, Steiner JF, Lum A, Barrett PH Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999;281:1512-9.
33. Trepka MJ, Belongia EA, Chyou PH, Davis JP, Schwartz B. The effect of a community intervention trial on parental knowledge and awareness of antibiotic resistance and appropriate antibiotic use in children. Pediatrics. 2001;107:E6.
34. Wheeler JG, Fair M, Simpson PM, Rowlands LA, Aitken ME, Jacobs RF. Impact of a waiting room videotape message on parent attitudes toward pediatric antibiotic use. Pediatrics. 2001;108:591-6.
35. Taylor JA, Kwan-Gett TS, McMahon EM Jr. Effectiveness of a parental educational intervention in reducing antibiotic use in children: a randomized controlled trial. Pediatr Infect Dis J. 2005;24:489-93.
36. Lambert MF, Masters GA, Brent SL. Can mass media campaigns change antimicrobial prescribing? A regional evaluation study. J Antimicrob Chemother. 2007;59:537-43. Epub 2007 Feb 5.